Trademarkia Logo

Canada

C$
TUNE THERAPEUTICS
ADVERTISED

on 9 Apr 2025

Last Applicant/ Owned by

Tune Therapeutics, Inc.

1616 Eastlake Avenue ESuite 208Seattle, Washington 98102

US

Serial Number

2066271 filed on 25th Nov 2020

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

TUNE THERAPEUTICS

Trademark usage description

biotechnology-formed genes for use in the manufacture of pharmaceuticals and therapeutics pharmaceuticals for the treatment of genetic diseases with Read More

Classification Information


Class [001]
Biotechnology-formed genes for use in the manufacture of pharmaceuticals and therapeutics


Classification kind code

11

Class [005]
Pharmaceuticals for the treatment of genetic diseases with a genetic mutation underpinning


Classification kind code

11

Class [042]
Research in the field of gene editing technology; research and development in the pharmaceutical and medical biotechnology fields; biotechnology research in the field of genetics


Classification kind code

11

Mark Details


Serial Number

2066271

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 9th Apr 2025
Advertised
Submitted for opposition 27
on 10th Mar 2025
Approval Notice Sent
Submitted for opposition 26
on 10th Mar 2025
Approved
Submitted for opposition 22
on 5th Sept 2024
Search Recorded
Submitted for opposition 20
on 5th Sept 2024
Examiner's First Report
Submitted for opposition 287
on 23rd Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 135
on 9th Nov 2021
Amendment to Application
Submitted for opposition 30
on 25th Nov 2020
Filed
Submitted for opposition 1
on 25th Nov 2020
Created
Submitted for opposition 31
on 25th Nov 2020
Formalized